NSEUpdates9 Jul 2026 · 9 Jul 2026, 10:45 pm

Updates

Blue Jet Healthcare Limited · BLUEJET

✦ AI SummaryFundraise

Blue Jet Healthcare Limited has informed the Exchange regarding 'outcome of Investment and Finance Committee' Meeting. The company has approved the issue and allotment of 15,810,276 Equity Shares eligible qualified institutional buyers at the issue price of ₹ 506.00 per Equity Share, aggregating ₹ 8000.00 million. The paid-up equity share capital of the Company stands increased from ₹ 346,930,850 to ₹ 378,551,402.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Blue Jet Healthcare Limited has informed the Exchange regarding 'outcome of Investment and Finance Committee' Meeting.

Attachments (1)

📄

BLUEJET_09072026224520_SE_Announcement__Allotment_Final.pdf

pdf

Download →
View document text
July 9, 2026 The Manager The Manager BSE Limited National Stock Exchange of India Limited P. J Towers, Dalal Street, Fort "Exchange Plaza", C-1, Block G, Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E), Scrip Code: 544009 Mumbai 400 051 Symbol: BLUEJET Dear Madam / Sir Sub: Disclosure of the details of allotment in the Issue (as defined hereinafter) by Blue Jet Healthcare Limited (the “Company”) in accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements), 2015, as amended (the “SEBI Listing Regulations”). Re: Qualified institutions placement of equity shares of face value of ₹ 2 each (the “Equity Shares”) by the Company under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”), and Sections 42 and 62 of the Companies Act, 2013 (including the rules made thereunder), as amended (the “Issue”). In continuation to the captioned subject, we wish to inform you that, in respect of the Issue which opened on July 6, 2026 and closed on July 9, 2026, the Investment and Finance Committee at its meeting held today, i.e., July 9, 2026, approved the issue and allotment of 15,810,276 Equity Shares eligible qualified institutional buyers at the issue price of ₹ 506.00 per Equity Share, i.e. at a premium of ₹ 504.00 per Equity Share, (which included a discount of Rs. 25.70 (4.83% of the floor price) to the floor price) aggregating ₹ 8000.00 million (rupees eight thousand million), pursuant to the Issue. Pursuant to the allotment of Equity Shares in the Issue, the paid-up equity share capital of the Company stands increased from ₹ 346,930,850 consisting of 173,465,425 Equity Shares of ₹ 2 each to ₹ 378,551,402 consisting of 189,275,701 Equity Shares of ₹2 each. The shareholding pattern of the Company, before and after the Issue, will be submitted along with the listing application in the format specified in Regulation 31 of the SEBI Listing Regulations. Further, find attached herewith the list of allottees who have been allotted more than 5% of the Equity Shares offered in the Issue, marked as Annexure 1. The information as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations Disclosure Requirements) Regulations, 2015, as amended, (“SEBI Listing Regulations”) read with Schedule - III part - A to the SEBI Listing Regulations, SEBI master circular no. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026, is as follows: Type of securities issued and allotted Equity Shares Type of Issuance Qualified Institutions Placement Total no. of securities issued 15,810,276 Equity Shares of face value of ₹ 2 each at a price of ₹ 506.00 per Equity Share (including a premium of ₹ 504.00 per Equity Share) Total amount for which securities issued ₹ 8,000 million The Issue opened on July 6, 2026 and closed on July 9, 2026 and the same was intimated to you through our letters dated July 6, 2026 and July 9, 2026 respectively. The meeting of the Investment and Finance Committee commenced at 10.10PM and concluded at 10.25PM. We request you to kindly take this on records, and the same be treated as compliance under the applicable regulations of the SEBI Listing Regulations. Thanking you Yours faithfully For Blue Jet Healthcare Limited Sweta Poddar Company Secretary and Compliance Officer Membership No: F12287 Annexure 1 S. Name of the Allottees No. of Equity PAN Clubbed % of % Category N Shares Allotted number of equity total (PAN o. shares allotted Issue Clubbe size d) 5% above SHAMYAK INVESTMENT SYSTEMICALLY 54,34,785 54,34,785 34.38 34.38 1. PRIVATE LIMITED IMPORTANT NON- BANKING FINANCIAL COMPANY - SI NBFC 2. ICICI PRUDENTIAL PHARMA HEALTHCARE AND 9,19,996 5.82 MUTUAL FUND - MF DIAGANOSTICS (P.H.D) FUND 3. ICICI PRUDENTIAL 12,87,994 8.15 MUTUAL FUND - MF MANUFACTURING FUND 4. ICICI PRUDENTIAL MNC FUND 3,31,198 2.09 MUTUAL FUND - MF 5. ICICI PRUDENTIAL QUANT 36,800 53,35,974 0.23 33.75 MUTUAL FUND - MF FUND 6. ICICI PRUDENTIAL EQUITY 9,19,996 5.82 MUTUAL FUND - MF SAVINGS FUND 7. ICICI PRUDENTIAL VALUE 16,55,991 10.47 MUTUAL FUND - MF FUND 8. ICICI PRUDENTIAL QUALITY 1,83,999 1.16 MUTUAL FUND - MF FUND